Favorable impact in Hepatitis C related mortality following free-access to direct-acting antivirals in Spain.

Julieta PolitiJuan-Miguel GuerrasMarta DonatMaría J BelzaElena RondaGregorio BarrioEnrique Regidor

Published in: Hepatology (Baltimore, Md.) (2021)

These results suggest that the favorable changes in HCV-related mortality observed for Spain after April 2015 are attributable to scaling up free treatment with direct-acting antivirals and reinforce that HCV eradication is on the horizon.

Keyphrases

hepatitis c virus
cardiovascular events
risk factors
human immunodeficiency virus
cardiovascular disease
type diabetes
combination therapy
smoking cessation
antiretroviral therapy